Allspring Global Investments’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$287K Sell
2,068
-3,112
-60% -$433K ﹤0.01% 1482
2025
Q1
$904K Sell
5,180
-24,597
-83% -$4.29M ﹤0.01% 1281
2024
Q4
$4.66M Sell
29,777
-81,928
-73% -$12.8M 0.01% 951
2024
Q3
$20.3M Sell
111,705
-64,741
-37% -$11.8M 0.03% 558
2024
Q2
$32.4M Buy
176,446
+18,021
+11% +$3.31M 0.05% 418
2024
Q1
$28.2M Buy
158,425
+99,101
+167% +$17.6M 0.04% 479
2023
Q4
$7.36M Buy
59,324
+4,588
+8% +$569K 0.01% 834
2023
Q3
$6.35M Buy
54,736
+53,606
+4,744% +$6.22M 0.01% 889
2023
Q2
$133K Buy
1,130
+29
+3% +$3.41K ﹤0.01% 1954
2023
Q1
$88.1K Buy
1,101
+140
+15% +$11.2K ﹤0.01% 2087
2022
Q4
$76.1K Sell
961
-20
-2% -$1.58K ﹤0.01% 2174
2022
Q3
$68K Buy
981
+709
+261% +$49.1K ﹤0.01% 2227
2022
Q2
$17K Sell
272
-3,388
-93% -$212K ﹤0.01% 2518
2022
Q1
$243K Buy
3,660
+376
+11% +$25K ﹤0.01% 2507
2021
Q4
$229K Buy
+3,284
New +$229K ﹤0.01% 2602